Top Markets
Coin of the day
TaiRx, Inc. TaiRx, Inc.

TaiRx, Inc.

6580
Kedudukan dalam Saham #25843
TaiRx, Inc., established in 2011 and headquartered in Taipei City, Taiwan, is a... TaiRx, Inc., established in 2011 and headquartered in Taipei City, Taiwan, is a pharmaceutical company dedicated to the research, development, and commercialization of therapeutic solutions for cancer and other diseases. The company's clinical pipeline includes CVM-1118, an oral anti-cancer drug currently undergoing Phase II clinical trials, and Rexis, an add-on injection therapy for sepsis patients, which is in Phase III trials. In its pre-clinical stage, TaiRx is developing TRX-711 for secondary hyperparathyroidism, TRX-920 as an oral delivery formulation, and TRX-105, a molecule designed to treat and alleviate symptoms of various types of colitis. Beyond its developmental drugs, TaiRx also offers Zelnite, a medication that helps maintain patients' blood selenium levels and supports their immune systems. The company's future endeavors also involve the development of nodal diagnostic devices and innovative antibody-based drugs.
Harga Saham
$0.40861751
Disegerakkan terakhir: 2026-08-20
Modal Pasaran
$45.81M
Perubahan (1 hari)
-1.15%
Perubahan (1 tahun)
-45.04%
Negara
TW
Perdagangan TaiRx, Inc. (6580)

Kategori

Sejarah pecahan saham untuk TaiRx, Inc. (6580)
Saham TaiRx, Inc. (simbol: 6580) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 21, 2026.
Satu saham 6580 yang dibeli sebelum Aug 21, 2026 kini bersamaan dengan 0 saham 6580.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US